Actively Recruiting

Phase Not Applicable
Age: 22Years - 49Years
FEMALE
NCT06983041

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Led by Coologics, Inc · Updated on 2026-01-30

55

Participants Needed

10

Research Sites

57 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this study is to determine clinical cure rate and safety of a proprietary Vaginal Cooling Device (VCD) in women with VCC. In addition, the safety, mycological cure rates, the speed and efficacy of symptom resolution, vaginal hyphae and polymorphonuclear (PMN) scores, and Quality-of-Life (QoL) parameters will be determined.

CONDITIONS

Official Title

Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)

Who Can Participate

Age: 22Years - 49Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 22 to 49 years and not more than one year since last menstrual period with suspected uncomplicated VVC
  • Able to read and understand English
  • Able to provide written informed consent and agree to all study procedures
  • Have a smartphone and can access and use the ValidCare app
  • Documented Pap test at baseline or within the past 12 months showing negative or ASCUS results and negative for high-risk HPV or negative colposcopy
  • Clinical diagnosis of symptomatic VVC confirmed by positive KOH wet mount and yeast culture at baseline
  • Presence of at least one vulvovaginal sign such as erythema, edema, or excoriation
  • Presence of at least one vulvovaginal symptom like itching, pain, burning, or irritation
  • Willing and able to avoid vaginal or any sexual activity during the study period
  • Allowed to use menstrual products such as tampons, pads, or menstrual cups during the study
Not Eligible

You will not qualify if you...

  • No smartphone or inability to use the ValidCare app
  • Treated for VVC within the past 14 days
  • Use of systemic, topical vulvar, or vaginal antibiotics, antifungals, or anti-trichomonas drugs within 14 days
  • Use of systemic corticosteroids, immunosuppressive, or immune-stimulating drugs within 3 months
  • History of douching within the previous 7 days
  • Current urinary tract infection
  • Unable or unwilling to use tampons
  • Unable to follow study protocol including avoidance of sexual activity during the 28-day study period
  • Use of anticoagulation therapy such as warfarin or heparin
  • Diabetes mellitus
  • History of vulvodynia, vestibulitis, vaginismus, radiation-induced vaginitis, or postmenopausal atrophy
  • Immune-compromised conditions such as HIV/AIDS or transplant recipients
  • Other infectious vulvovaginitis or mixed infections diagnosed at baseline
  • Symptomatic vulvar or vaginal condyloma or other vaginal/vulvar conditions that could affect clinical response
  • Pregnancy
  • Presence of trichomonad trophozoites on initial wet smear
  • Any condition that investigators determine would preclude participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

Symphony Clinical Research

Jacksonville, Florida, United States, 32224

Actively Recruiting

2

Nova Clinical Research

Miami, Florida, United States, 33162

Actively Recruiting

3

Pivotal Clinical Research & Associates

Smyrna, Georgia, United States, 30082

Actively Recruiting

4

Renew Health Clinical Research

Snellville, Georgia, United States, 30078

Actively Recruiting

5

Leavitt Clinical Research

Idaho Falls, Idaho, United States, 83404

Suspended

6

Next Innovative Clinical Research

Chicago, Illinois, United States, 60616

Actively Recruiting

7

Unified Women's Clinical Research-Raleigh

Raleigh, North Carolina, United States, 27607

Actively Recruiting

8

Lyndhurst Clinical Research

Winston-Salem, North Carolina, United States, 27103

Actively Recruiting

9

Aviati Health

Memphis, Tennessee, United States, 38115

Active, Not Recruiting

10

Vilo Research Group, Inc.

Houston, Texas, United States, 77070

Actively Recruiting

Loading map...

Research Team

K

Kimberly J Langdon, MD

CONTACT

K

Keith Aqua, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here